Ascent Scientific expands Low-Cost Ligand™ glutamate range - to help research into neurological disorders

(PRLEAP.COM) Ascent Scientific (www.ascentscientific.com) announced the expansion of its Low-Cost Ligand ™ glutamate range – chemical tools that will aid research into a wide range of neurological disorders. The range includes groundbreaking research tools such as Fenobam, MTEP, and YM-298198 and will aid research into disorders such as anxiety, pain, Alzheimers, epilepsy and stress-related conditions.
Steve Roome PhD, Commercial Director commented, “Our newly expanded range includes exciting new research tools such as Fenobam, MTEP and the novel YM-298198, which is currently only available from Ascent Scientific. In addition, we have introduced a range of popular standard tools including CNQX and MK-801. The expanded Low-Cost Ligand™ glutamate range is particularly special, as the tools are offered at prices up to 50% less than other suppliers – in keeping with our philosophy to make research tools affordable for as many researchers as possible.”

Contact: Steve Roome, Commercial Director +44 (0)1934 624 695 steveroome@ascentscientific.co.uk

About Ascent Scientific
Ascent Scientific provides high quality receptor ligands, synthetic chemistry, research, consultancy and analytical services for life science, pharmaceutical and chemistry-related industries.

The Low-Cost Ligand™ range includes glutamate, histamine, purinergic and vanilloid receptor ligands together with signalling tools. The glutamate range includes:
AMN082: the first selective mGlu7 agonist
D-AP5: Potent selective NMDA antagonist
L-AP4: selective group III mGlu agonist
CNQX: AMPA/Kainate receptor antagonist
Fenobam: novel mGlu5 antagonist
(+)-MK 801: potent, selective NMDA antagonist
MTEP: brain penetrant, selective mGlu5 antagonist
MPEP: mGlu5 selective antagonist
YM298198: potent, selective mGlu1 antagonist

ENDS